NCT00254956View on ClinicalTrials.gov

Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

1,568

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Respiratory Tract DiseasesRespiratory HypersensitivityAsthma
Interventions
DRUG

ciclesonide (XRP1526)

Trial Locations (1)

91380

Sanofi-Aventis, Chilly-Mazarin

Sponsors

Lead Sponsor

Sanofi

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Sanofi

INDUSTRY

NCT00254956 - Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma | Biotech Hunter | Biotech Hunter